We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Crucial Mitophagy Protein Identified

By LabMedica International staff writers
Posted on 05 Jan 2017
A receptor protein located on the inner mitochondrial membrane has been identified as a critical initiator of the process of mitochondrial destruction known as mitophagy.

The removal of unwanted or damaged mitochondria by the autophagic process known as mitophagy is essential for key events in development, cellular homeostasis, tumor suppression, and prevention of neurodegeneration and aging. More...
However, the precise mechanisms of mitophagy have not been elucidated.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) unraveled some of the secrets of mitophagy and described their findings in the December 22, 2016, online edition of the journal Cell.

They reported that they had identified the inner mitochondrial membrane protein, prohibitin 2 (PHB2), as a crucial mitophagy receptor involved in targeting mitochondria for autophagic degradation. PHB2 is located on the inner membrane of mitochondria, but is exposed when a mitochondrion's outer membrane ruptures. Should this occur, the LC3 (Microtubule-associated proteins 1A/1B light chain 3A) protein, which is present on the exterior of autophagosomes binds to PHB2. The autophagosome then transports the damaged mitochondrion to be destroyed by a lysosome.

The investigators also found that PHB2 was required for mitophagy induced by Parkin protein in mammalian cells and for the clearance of paternal mitochondria after embryonic fertilization in the flatworm C. elegans.

"The removal of damaged mitochondria by autophagy (a process called mitophagy) is important for cellular health," said senior author Dr. Beth Levine, professor of internal medicine and microbiology at the University of Texas Southwestern Medical Center. "By understanding how cells get rid of damaged mitochondria that contribute to cancer, neurodegenerative diseases, and aging, we may be able to develop treatments to prevent those processes."

Related Links:
University of Texas Southwestern Medical Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.